Lantern Pharma Inc.
NASDAQ:LTRN

Watchlist Manager
Lantern Pharma Inc. Logo
Lantern Pharma Inc.
NASDAQ:LTRN
Watchlist
Price: 3.53 USD -1.4% Market Closed
Market Cap: 38m USD
Have any thoughts about
Lantern Pharma Inc.?
Write Note

Wall Street
Price Targets

LTRN Price Targets Summary
Lantern Pharma Inc.

Wall Street analysts forecast LTRN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LTRN is 22.44 USD with a low forecast of 18.18 USD and a high forecast of 27.3 USD.

Lowest
Price Target
18.18 USD
415% Upside
Average
Price Target
22.44 USD
536% Upside
Highest
Price Target
27.3 USD
673% Upside
Lantern Pharma Inc. Competitors:
Price Targets
SOBI
Swedish Orphan Biovitrum AB (publ)
9% Upside
AELIS
Aelis Farma SA
413% Upside
EQ
Equillium Inc
782% Upside
GLPG
Galapagos NV
52% Upside
1801
Innovent Biologics Inc
59% Upside
VCYT
Veracyte Inc
4% Downside
CYTK
Cytokinetics Inc
50% Upside
HOWL
Werewolf Therapeutics Inc
497% Upside

Revenue
Forecast

Revenue Estimate
Lantern Pharma Inc.

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Lantern Pharma Inc.

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Lantern Pharma Inc.

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LTRN's stock price target?
Price Target
22.44 USD

According to Wall Street analysts, the average 1-year price target for LTRN is 22.44 USD with a low forecast of 18.18 USD and a high forecast of 27.3 USD.

Back to Top